Last reviewed · How we verify
Live Francisella Tularensis Vaccine
Live Francisella Tularensis Vaccine is a Biologic drug developed by U.S. Army Medical Research and Development Command. It is currently in Phase 2 development. Also known as: LVS Vaccine.
At a glance
| Generic name | Live Francisella Tularensis Vaccine |
|---|---|
| Also known as | LVS Vaccine |
| Sponsor | U.S. Army Medical Research and Development Command |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine (PHASE2)
- Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine (PHASE2)
- Phase II Tularemia Vaccine Comparison (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Live Francisella Tularensis Vaccine CI brief — competitive landscape report
- Live Francisella Tularensis Vaccine updates RSS · CI watch RSS
- U.S. Army Medical Research and Development Command portfolio CI
Frequently asked questions about Live Francisella Tularensis Vaccine
What is Live Francisella Tularensis Vaccine?
Live Francisella Tularensis Vaccine is a Biologic drug developed by U.S. Army Medical Research and Development Command.
Who makes Live Francisella Tularensis Vaccine?
Live Francisella Tularensis Vaccine is developed by U.S. Army Medical Research and Development Command (see full U.S. Army Medical Research and Development Command pipeline at /company/u-s-army-medical-research-and-development-command).
Is Live Francisella Tularensis Vaccine also known as anything else?
Live Francisella Tularensis Vaccine is also known as LVS Vaccine.
What development phase is Live Francisella Tularensis Vaccine in?
Live Francisella Tularensis Vaccine is in Phase 2.
Related
- Manufacturer: U.S. Army Medical Research and Development Command — full pipeline
- Also known as: LVS Vaccine
- Compare: Live Francisella Tularensis Vaccine vs similar drugs
- Pricing: Live Francisella Tularensis Vaccine cost, discount & access